Construction and co-expression of plasmid encoding xylitol dehydrogenase and a cofactor regeneration enzyme for the production of xylitol from D-arabitol.
Peng Zhou, Sha Li, Hong Xu, Xiaohai Feng, Pingkai Ouyang
Index: Enzyme Microb. Technol. 51(2) , 119-24, (2012)
Full Text: HTML
Abstract
The biotransformation of D-arabitol into xylitol was investigated with focus on the conversion of D-xylulose into xylitol. This critical conversion was accomplished using Escherichia coli to co-express a xylitol dehydrogenase gene from Gluconobacter oxydans and a cofactor regeneration enzyme gene which was a glucose dehydrogenase gene from Bacillus subtilis for system 1 and an alcohol dehydrogenase gene from G. oxydans for system 2. Both systems efficiently converted D-xylulose into xylitol without the addition of expensive NADH. Approximately 26.91 g/L xylitol was obtained from around 30 g/L D-xylulose within system 1 (E. coli Rosetta/Duet-xdh-gdh), with a 92% conversion yield, somewhat higher than that of system 2 (E. coli Rosetta/Duet-xdh-adh, 24.9 g/L, 85.2%). The xylitol yields for both systems were more than 3-fold higher compared to that of the G. oxydans NH-10 cells (7.32 g/L). The total turnover number (TTN), defined as the number of moles of xylitol formed per mole of NAD(+), was 32,100 for system 1 and 17,600 for system 2. Compared with that of G. oxydans NH-10, the TTN increased by 21-fold for system 1 and 11-fold for system 2, hence, the co-expression systems greatly enhanced the NADH supply for the conversion, benefiting the practical synthesis of xylitol.Copyright © 2012 Elsevier Inc. All rights reserved.
Related Compounds
Related Articles:
Diagnostic use of cerebral and extracerebral oxysterols.
2004-02-01
[Clin. Chem. Lab Med. 42(2) , 186-91, (2004)]
2002-01-01
[Neurobiol. Aging 23(3) , 383-8, (2002)]
Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease.
1996-02-01
[Clin. Chem. 42(2) , 298-302, (1996)]
Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia.
2003-01-01
[Neurobiol. Aging 24(2) , 333-8, (2003)]
2001-03-01
[Arch. Neurol. 58(3) , 392-6, (2001)]